Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
- PMID: 30479095
- PMCID: PMC6304408
- DOI: 10.3802/jgo.2019.30.e11
Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
Abstract
Objective: Elderly age is one of the poor prognostic factors in epithelial ovarian cancer (EOC), but the optimal age cut-off is not known. The present study sought to identify the ideal age cutoff that represents a negative prognostic factor in EOC, considering the geriatric assessment.
Methods: Hazard ratios (HRs) with p-values were calculated using all possible age cutoffs with stage, histology, grade, optimality and comorbidities as covariates in multivariate Cox regression model. The trends of p-value and HR by age cutoff were further evaluated in a subgroup of histology and in The Cancer Genome Atlas (TCGA) dataset. In addition, propensity score-matching analysis using the identified age cutoff was performed.
Results: An age of 66 years was shown to be the most significant cutoff for defining old age with independent prognostic power (HR=1.45; 95% confidence interval=1.04-2.03; p=0.027). This result was also observed with the analyses of serous histology subgroup and with the analysis of a TCGA dataset with serous EOC. In survival analysis, patients aged ≥66 years had significantly worse overall survival compared with younger individuals (56 months vs. 87 months; p=0.006), even following propensity score matching (57 vs. 78 months; p=0.038).
Conclusion: An age of 66 years is the best cutoff to define elderly age in serous EOC patients considering the geriatric assessment, and this information can be used in the administration of individualized therapies in elderly EOC patients.
Keywords: Elderly; Epithelial Ovarian Cancer; Geriatric Assessment; Prognosis; Propensity Score-Matching.
Copyright © 2019. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures



Similar articles
-
Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.J Gynecol Oncol. 2018 Jan;29(1):e13. doi: 10.3802/jgo.2018.29.e13. J Gynecol Oncol. 2018. PMID: 29185271 Free PMC article.
-
High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.J Ovarian Res. 2016 Jul 7;9(1):41. doi: 10.1186/s13048-016-0247-6. J Ovarian Res. 2016. PMID: 27388275 Free PMC article.
-
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y. J Exp Clin Cancer Res. 2017. PMID: 28482906 Free PMC article.
-
Who are the long-term survivors of high grade serous ovarian cancer?Gynecol Oncol. 2018 Jan;148(1):204-212. doi: 10.1016/j.ygyno.2017.10.032. Epub 2017 Nov 8. Gynecol Oncol. 2018. PMID: 29128106 Review.
-
[Epithelial ovarian cancer and elderly patients. Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].Gynecol Obstet Fertil Senol. 2019 Feb;47(2):238-249. doi: 10.1016/j.gofs.2018.12.008. Epub 2019 Feb 1. Gynecol Obstet Fertil Senol. 2019. PMID: 30712964 Review. French.
Cited by
-
Value analysis of preoperative peripheral blood LMR in predicting prognosis of serous papillary ovarian adenocarcinoma.Discov Oncol. 2024 Aug 28;15(1):377. doi: 10.1007/s12672-024-01264-x. Discov Oncol. 2024. PMID: 39196433 Free PMC article.
-
Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study.J Gynecol Oncol. 2022 Jan;33(1):e5. doi: 10.3802/jgo.2022.33.e5. Epub 2021 Oct 13. J Gynecol Oncol. 2022. PMID: 34783208 Free PMC article.
-
A Novel Clinical Nomogram for Predicting Cancer-Specific Survival in Adult Patients After Primary Surgery for Epithelial Ovarian Cancer: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database and External Validation in a Tertiary Center.Front Oncol. 2021 Apr 20;11:670644. doi: 10.3389/fonc.2021.670644. eCollection 2021. Front Oncol. 2021. PMID: 33959514 Free PMC article.
-
Differences in Treatment Modalities and Prognosis of Elderly Patients with Ovarian Cancer: A Two-Center Propensity Score-Matched Study.Cancers (Basel). 2022 Jul 27;14(15):3655. doi: 10.3390/cancers14153655. Cancers (Basel). 2022. PMID: 35954319 Free PMC article.
-
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?Gynecol Oncol. 2025 Aug 13;201:60-68. doi: 10.1016/j.ygyno.2025.08.016. Online ahead of print. Gynecol Oncol. 2025. PMID: 40812120
References
-
- Sopik V, Iqbal J, Rosen B, Narod SA. Why have ovarian cancer mortality rates declined? part I. Incidence. Gynecol Oncol. 2015;138:741–749. - PubMed
-
- Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev. 2017;26:444–457. - PubMed
-
- Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27:2758–2765. - PubMed
-
- Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94:2766–2792. - PubMed
-
- Yancik R, Ries LA. Cancer in older persons: an international issue in an aging world. Semin Oncol. 2004;31:128–136. - PubMed